Corient Private Wealth LLC Sells 59,449 Shares of MetLife, Inc. (NYSE:MET)

Corient Private Wealth LLC lessened its holdings in shares of MetLife, Inc. (NYSE:MET) by 9.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 569,553 shares of the financial services provider’s stock after selling 59,449 shares during the quarter. Corient Private Wealth LLC owned approximately 0.08% of MetLife worth $46,577,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Bank of New York Mellon Corp increased its holdings in shares of MetLife by 109.2% during the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after acquiring an additional 4,606,748 shares during the last quarter. Swedbank AB boosted its position in MetLife by 76.0% during the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after purchasing an additional 1,496,645 shares during the period. Zurich Insurance Group Ltd FI acquired a new position in MetLife during the third quarter valued at approximately $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its position in shares of MetLife by 79.1% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after purchasing an additional 762,291 shares during the period. Finally, Jacobs Levy Equity Management Inc. lifted its stake in shares of MetLife by 256.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock worth $78,209,000 after buying an additional 682,333 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Price Performance

NYSE:MET opened at $82.23 on Tuesday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The company has a 50-day moving average of $83.45 and a 200-day moving average of $82.54. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05. The company has a market capitalization of $56.02 billion, a price-to-earnings ratio of 13.77, a PEG ratio of 0.65 and a beta of 1.04.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were paid a dividend of $0.545 per share. The ex-dividend date of this dividend was Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.65%. MetLife’s dividend payout ratio is currently 36.52%.

Wall Street Analysts Forecast Growth

MET has been the topic of a number of research analyst reports. Cowen reiterated a “buy” rating on shares of MetLife in a report on Friday, March 7th. Keefe, Bruyette & Woods dropped their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 12th. Wells Fargo & Company increased their target price on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. JPMorgan Chase & Co. lifted their price target on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Finally, Barclays reduced their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.58.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.